Literature DB >> 23340313

Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Kassandre Leongson1, Vincent Cousineau-Côté, Mathieu Goupil, Francine Aumont, Serge Sénéchal, Louis Gaboury, Paul Jolicoeur, James W Kronstad, Louis de Repentigny.   

Abstract

Cryptococcus neoformans var. grubii is the most frequent cause of AIDS-associated cryptococcosis worldwide, while Cryptococcus gattii usually infects immunocompetent people. To understand the mechanisms which cause differential susceptibility to these cryptococcal species in HIV infection, we established and characterized a model of cryptococcosis in CD4C/HIV(MutA) transgenic (Tg) mice expressing gene products of HIV-1 and developing an AIDS-like disease. Tg mice infected intranasally with C. neoformans var. grubii strain H99 or C23 consistently displayed reduced survival compared to non-Tg mice at three graded inocula, while shortened survival of Tg mice infected with C. gattii strain R265 or R272 was restricted to a single high inoculum. HIV-1 transgene expression selectively augmented systemic dissemination to the liver and spleen for strains H99 and C23 but not strains R265 and R272. Histopathologic examination of lungs of Tg mice revealed large numbers of widely scattered H99 cells, with a minimal inflammatory cell response, while in the non-Tg mice H99 was almost completely embedded within extensive mixed inflammatory cell infiltrates. In contrast to H99, R265 was dispersed throughout the lung parenchyma and failed to induce a strong inflammatory response in both Tg and non-Tg mice. HIV-1 transgene expression reduced pulmonary production of CCL2 and CCL5 after infection with H99 or R265, and production of these two chemokines was lower after infection with R265. These results indicate that an altered immune response in these Tg mice markedly enhances C. neoformans but not C. gattii infection. This model therefore provides a powerful new tool to further investigate the immunopathogenesis of cryptococcosis.

Entities:  

Mesh:

Year:  2013        PMID: 23340313      PMCID: PMC3639619          DOI: 10.1128/IAI.01339-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

1.  Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Authors:  Mathieu Goupil; Emilie Bélanger Trudelle; Véronique Dugas; Catherine Racicot-Bergeron; Francine Aumont; Serge Sénéchal; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

2.  Iron-regulated transcription and capsule formation in the fungal pathogen Cryptococcus neoformans.

Authors:  Tianshun Lian; Megan I Simmer; Cletus A D'Souza; Barbara R Steen; Scott D Zuyderduyn; Steven J M Jones; Marco A Marra; James W Kronstad
Journal:  Mol Microbiol       Date:  2005-03       Impact factor: 3.501

3.  Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.

Authors:  Daniel Lewandowski; Miriam Marquis; Francine Aumont; Annie-Claude Lussier-Morin; Marianne Raymond; Serge Sénéchal; Zaher Hanna; Paul Jolicoeur; Louis de Repentigny
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

4.  Mechanisms of impaired anticryptococcal activity of monocytes from donors infected with human immunodeficiency virus.

Authors:  T S Harrison; S M Levitz
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

Review 5.  Intracellular parasitism of macrophages by Cryptococcus neoformans.

Authors:  M Feldmesser; S Tucker; A Casadevall
Journal:  Trends Microbiol       Date:  2001-06       Impact factor: 17.079

6.  Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1.

Authors:  Louis de Repentigny; Francine Aumont; Jean-Sébastien Ripeau; Marie Fiorillo; Denis G Kay; Zaher Hanna; Paul Jolicoeur
Journal:  J Infect Dis       Date:  2002-03-21       Impact factor: 5.226

7.  The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells.

Authors:  Johanne Poudrier; Xiaoduan Weng; Denis G Kay; Zaher Hanna; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 8.  Spread of Cryptococcus gattii into Pacific Northwest region of the United States.

Authors:  Kausik Datta; Karen H Bartlett; Rebecca Baer; Edmond Byrnes; Eleni Galanis; Joseph Heitman; Linda Hoang; Mira J Leslie; Laura MacDougall; Shelley S Magill; Muhammad G Morshed; Kieren A Marr
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

9.  Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS.

Authors:  Simon Swingler; Jin Zhou; Catherine Swingler; Ann Dauphin; Thomas Greenough; Paul Jolicoeur; Mario Stevenson
Journal:  Cell Host Microbe       Date:  2008-07-17       Impact factor: 21.023

10.  Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans.

Authors:  J L Curtis; G B Huffnagle; G H Chen; M L Warnock; M R Gyetko; R A McDonald; P J Scott; G B Toews
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

View more
  8 in total

1.  Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection.

Authors:  George R Thompson; Nathaniel Albert; Greg Hodge; Machelle D Wilson; Jane E Sykes; Derek J Bays; Carolina Firacative; Wieland Meyer; Dimitrios P Kontoyiannis
Journal:  Infect Immun       Date:  2014-05-05       Impact factor: 3.441

2.  Conservation of Intracellular Pathogenic Strategy among Distantly Related Cryptococcal Species.

Authors:  Joudeh B Freij; Man Shun Fu; Carlos M De Leon Rodriguez; Amanda Dziedzic; Anne E Jedlicka; Quigly Dragotakes; Diego C P Rossi; Eric H Jung; Carolina Coelho; Arturo Casadevall
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

3.  Cryptococcus gattii alters immunostimulatory potential in response to the environment.

Authors:  Keigo Ueno; Yoshiko Otani; Nao Yanagihara; Takumi Nakamura; Kiminori Shimizu; Satoshi Yamagoe; Yoshitsugu Miyazaki
Journal:  PLoS One       Date:  2019-08-09       Impact factor: 3.240

4.  Phagosomal F-Actin Retention by Cryptococcus gattii Induces Dendritic Cell Immunoparalysis.

Authors:  Khusraw Jamil; Maria J Polyak; David D Feehan; Philip Surmanowicz; Danuta Stack; Shu Shun Li; Henry Ogbomo; Michal Olszewski; Anutosh Ganguly; Christopher H Mody
Journal:  mBio       Date:  2020-11-24       Impact factor: 7.867

Review 5.  Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.

Authors:  Josie F Gibson; Simon A Johnston
Journal:  Fungal Genet Biol       Date:  2014-12-12       Impact factor: 3.495

6.  Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.

Authors:  Tomomi Saijo; Jianghan Chen; Sharon C-A Chen; Lindsey B Rosen; Jin Yi; Tania C Sorrell; John E Bennett; Steven M Holland; Sarah K Browne; Kyung J Kwon-Chung
Journal:  MBio       Date:  2014-03-18       Impact factor: 7.867

7.  Antifungal activity of topical microemulsion containing a thiophene derivative.

Authors:  Geovani Pereira Guimarães; Mysrayn Yargo de Freitas Araújo Reis; Dayanne Tomaz Casimiro da Silva; Francisco Jaime Bezerra Mendonça Junior; Attílio Converti; Adalberto Pessoa; Bolívar Ponciano Goulart de Lima Damasceno; José Alexsandro da Silva
Journal:  Braz J Microbiol       Date:  2014-08-29       Impact factor: 2.476

8.  Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure.

Authors:  Makoto Urai; Yukihiro Kaneko; Keigo Ueno; Yoichiro Okubo; Tomoko Aizawa; Hidesuke Fukazawa; Takashi Sugita; Hideaki Ohno; Kazutoshi Shibuya; Yuki Kinjo; Yoshitsugu Miyazaki
Journal:  Front Cell Infect Microbiol       Date:  2016-01-06       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.